Mergers & Acquisitions - Shire

Filter

Current filters:

Shire

Popular Filters

126 to 150 of 904 results

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

12-12-2013

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

ActavisGenericsMergers & AcquisitionsNorth AmericaRegulationReproductiveWarner Chilcott

Emergent BioSolutions to acquire Cangene for $222 million

12-12-2013

Taking a significant step to solidify its leadership position in the growing biodefense market, US vaccine…

CangeneEmergent BioSolutionsMergers & AcquisitionsNorth AmericaPharmaceuticalVaccines

Actavis sells 51% stake in Russian subsidiary

Actavis sells 51% stake in Russian subsidiary

10-12-2013

Leading global generics drugmaker Actavis says that it sold its 51% stake in the Russian drug company…

ActavisEastern EuropeFarmekoGenericsMergers & AcquisitionsRussiaZio-Zdorovye

Report: Life science companies experience IPO slowdown

10-12-2013

Life sciences companies have been completing fewer initial public offerings (IPOs) this season as the…

Mergers & AcquisitionsPharmaceuticalRocheSalix PharmaceuticalsShireUSA

Advaxis rockets on out-licensing ADXS-HPV in Asia

09-12-2013

Shares of US cancer drug developer Advaxis leapt 22% to $4.38 in pre-market trading as the company revealed…

AdvaxisADXS-HPVBiotechnologyGlobal BioPharmaLicensingMergers & AcquisitionsOncologyTaiwan Biotech

Shire reports mixed results from Phase III study of lifitegrast in dry eye disease

Shire reports mixed results from Phase III study of lifitegrast in dry eye disease

09-12-2013

Ireland-headquartered drugmaker Shire (LSE: SHP) has announced mixed results from a Phase III efficacy…

EuropeLifitegrastOphthalmicsPharmaceuticalResearchShire

Grunenthal launches public tender offer to acquire Andromaco

04-12-2013

German family-owned drugmaker Grunenthal Group has now published its public tender offer to acquire all…

ChileGrunenthalLaboratorios AndromacoMergers & AcquisitionsPharmaceuticalSouth America

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

03-12-2013

UK drugmaker Shire says that its subsidiary Shire US Inc has entered into an agreement to supply an authorized…

Adderall XRGenericsLicensingNeurologicalNorth AmericaNovartisSandozShire

PharmAthene pulls out of merger deal with Theraclone

03-12-2013

USA-based biodefense company PharmAthene has decided to terminate its previously-announced all stock…

Mergers & AcquisitionsPharmaceuticalPharmAtheneTheraclone Sciences

Biozone Pharma plans reverse merger with Cocrystal Discovery

03-12-2013

USA-based Biozone Pharmaceuticals shares dropped nearly 5.5% when it revealed last week it had agreed…

Anti-viralsBiotechnologyBiozone PharmaceuticalsCocrystal DiscoveryMergers & Acquisitions

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

Report 1: Growth strategies in Japan’s pharma market, by P Reed Maurer

02-12-2013

P Reed Maurer, long-time Japanese pharma industry watcher and president of International Alliances Limited,…

Asia-PacificMergers & AcquisitionsPharmaceutical

Polpharma manufacturing division assimilates Sanfarm in Nowa Dęba

30-11-2013

Sanfarm, a company operating in the Tarnobrzeg Economic Zone in Poland, has become part of leading Polish…

Eastern EuropeGenericsMergers & AcquisitionsPolpharmaProductionSanfarm

KKR acquires $200 million stake in India’s Gland Pharma

KKR acquires $200 million stake in India’s Gland Pharma

29-11-2013

Indian injectable generic firm Gland Pharma says it has reached an agreement under which Kohlberg Kravis…

Asia-PacificGenericsGland PharmaMergers & Acquisitions

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

28-11-2013

South African drugmaker Adcock Ingram yesterday made the case for accepting a takeover from Chile largest…

Adcock IngramCFR PharmaceuticalsFinancialMergers & AcquisitionsPharmaceuticalRest of the World

Korea’s SillaJen to acquire Jennerex in up to $150 million deal

Korea’s SillaJen to acquire Jennerex in up to $150 million deal

27-11-2013

Privately-held South Korean firm SillaJen says it has executed a definitive merger agreement to acquire…

BiotechnologyJennerexMergers & AcquisitionsOncologyPexa-VecSillaJenTransgene

EU Commission clears acquisition of Life Technologies by Thermo Fisher, subject to conditions

26-11-2013

The European Commission has cleared under the EU Merger Regulation the proposed $13.6 billion acquisition…

EuropeLife TechnologiesMergers & AcquisitionsPharmaceuticalThermo Fisher Scientific

NicOx sets up shop in Italy with Eupharmed acquisition

26-11-2013

French biotechnology firm NicOx is planning to establish itself in Italy through a proposed acquisition…

EupharmedItalyMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

Norway’s Algeta confirms takeover bid approach from Bayer

Norway’s Algeta confirms takeover bid approach from Bayer

26-11-2013

In response to recent media commentary, the board of directors of Norway’s Algeta this morning confirmed…

AlgetaBayerMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

126 to 150 of 904 results

Back to top